Diabetes medication: Difference between revisions
Created page with "{{Short description|Drugs that lower blood glucose levels to treat diabetes}} {{About|treatment of diabetes mellitus|treatment of diabetes insipidus|Diabetes insipidus}} '''Drugs used in diabetes''' treat diabetes mellitus by decreasing the glucose level in the blood. With the exception of insulin, most GLP receptor agonists (liraglutide, exenatide, and others), and pramlintide, all are administered orall..." |
|||
| Line 84: | Line 84: | ||
===Sulfonylureas=== | ===Sulfonylureas=== | ||
{{Main|Sulfonylurea}} | {{Main|Sulfonylurea}} | ||
[[Sulfonylurea]]s were the first widely used oral anti-hyperglycemic medications. They are ''insulin secretagogues'', triggering insulin release by inhibiting the [[ATP-sensitive potassium channel|K<sub>ATP</sub>]] channel of the pancreatic [[beta cell]]s. Eight types of these pills have been marketed in North America, but not all remain available. The "second-generation" drugs are now more commonly used. They are more effective than first-generation drugs and have fewer side-effects. All may cause weight gain. | [[Sulfonylurea]]s were the first widely used oral anti-hyperglycemic medications. They are ''insulin secretagogues'', triggering insulin release by inhibiting the [[ATP-sensitive potassium channel|K<sub>ATP</sub>]] channel of the pancreatic [[beta cell]]s. Eight types of these pills have been marketed in North America, but not all remain available. The "second-generation" drugs are now more commonly used. They are more effective than first-generation drugs and have fewer side-effects. All may cause weight gain. | ||